Sökning: WFRF:(Biggin Andrew) >
Patient-reported ou...
Patient-reported outcomes from a randomized open-label phase 3 trial comparing burosumab versus conventional therapy in children with X-linked hypophosphatemia : results from the 24-week treatment extension period
-
- Padidela, Raja (författare)
- Department of Paediatric Endocrinology, Royal Manchester Children’s Hospital, Manchester, United Kingdom; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom
-
- Whyte, Michael P. (författare)
- Shriners Hospitals for Children - Washington University School of Medicine in St Louis, St Louis MO, USA
-
- Glorieux, Francis H. (författare)
- Shriners Hospital for Children – Canada, McGill University, Montreal QC, Canada
-
visa fler...
-
- Munns, Craig F. (författare)
- The University of Sydney Children’s Hospital Westmead Clinical School, The Children’s Hospital at Westmead, Westmead, NSW, Australia; Department of Endocrinology, The Children’s Hospital at Westmead, Westmead NSW, Australia
-
- Ward, Leanne M. (författare)
- Department of Pediatrics, University of Ottawa, Ottawa ON, Canada; Division of Endocrinology and Metabolism, Children’s Hospital of Eastern Ontario, Ottawa ON, Canada
-
- Nilsson, Ola, 1970- (författare)
- Örebro universitet,Institutionen för medicinska vetenskaper,Division of Pediatric Endocrinology & Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden
-
- Portale, Anthony A. (författare)
- Department of Pediatrics, University of California, San Francisco CA, USA
-
- Simmons, Jill H. (författare)
- Department of Pediatrics, Division of Endocrinology and Diabetes, Vanderbilt University School of Medicine, Vanderbilt University, Nashville TN, USA
-
- Namba, Noriyuki (författare)
- Department of Pediatrics, Osaka Hospital, Japan Community Healthcare Organization, Osaka, Japan; Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan
-
- Cheong, Hae Il (författare)
- Department of Pediatrics, Hallym University Sacred Heart Hospital, Anyang, Republic of South Korea
-
- Pitukcheewanont, Pisit (författare)
- Center of Endocrinology, Diabetes and Metabolism, Children’s Hospital Los Angeles, Los Angeles CA, USA
-
- Sochett, Etienne (författare)
- Department of Paediatrics, Hospital for Sick Children, Toronto ON, Canada
-
- Högler, Wolfgang (författare)
- Department of Paediatrics and Adolescent Medicine, Johannes Kepler University Linz, Linz, Austria; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom
-
- Muroya, Koji (författare)
- Department of Endocrinology and Metabolism, Kanagawa Children’s Medical Center, Yokohama, Japan
-
- Gottesman, Gary S. (författare)
- Shriners Hospitals for Children, St Louis MO, USA
-
- Biggin, Andrew (författare)
- The University of Sydney Children’s Hospital Westmead Clinical School, The Children’s Hospital at Westmead, Westmead NSW, Australia
-
- Perwad, Farzana (författare)
- Department of Pediatrics, University of California, San Francisco CA, USA
-
- Williams, Angela (författare)
- Kyowa Kirin International, Marlow, United Kingdom
-
- Nixon, Annabel (författare)
- Chilli Consultancy, Salisbury, United Kingdom
-
- Sun, Wei (författare)
- Kyowa Kirin Pharmaceutical Development, Princeton NJ, USA
-
- Chen, Angel (författare)
- Department of Medicine and Department of Pediatrics, Indiana University School of Medicine, Indianapolis IN, USA
-
- Skrinar, Alison (författare)
- Ultragenyx Pharmaceutical, Novato CA, USA
-
- Imel, Erik A. (författare)
- Department of Medicine and Department of Pediatrics, Indiana University School of Medicine, Indianapolis IN, USA
-
visa färre...
-
(creator_code:org_t)
- S. Karger, 2022
- 2022
- Engelska.
-
Ingår i: Hormone Research in Paediatrics. - : S. Karger. - 1663-2818 .- 1663-2826. ; 95:Suppl. 2, s. 29-30
- Relaterad länk:
-
https://urn.kb.se/re...
Abstract
Ämnesord
Stäng
- In a randomized open-label phase 3 trial in 62 children (1–12 years) with X-linked hypophosphatemia (XLH) (NCT 02915705), switching from conventional therapy (oral phosphate plus active vitamin D) to burosumab, a monoclonal antibody targeting fibroblast growth factor 23, significantly improved serum phosphate concentration, rickets, lower-extremity deformities, growth, mobility, and patient-reported outcomes (PROs) at 64 weeks. Children in Europe, USA, Canada, and Australia who completed 64 weeks’ treatment could continue to receive burosumab in the extension period (burosumab continuation group) or cross over from conventional therapy to burosumab (crossover group) to 124 weeks. A Patient-Reported Outcomes Measurement Information System (PROMIS) questionnaire was used in children aged ≥5 years to measure Pain Interference, Physical Function Mobility, and Fatigue; health-related quality of life was measured using the SF-10 Health Survey for Children (n=35). Here, we describe changes in PROs from baseline to weeks 64 and 88, and report whether the 3-point minimal important difference (MID) was reached for PROMIS domains (Thissen et al., 2016; PMID 26118768). The mean change from baseline exceeded the MID for Pain Interference at weeks 64 and 88 and for Fatigue at week 64 in the burosumab continuation group, and for Pain Interference and Fatigue at week 88 in the crossover group. Similar improvements in SF-10 Physical Health were seen baseline to week 64 in the burosumab continuation group, and week 64 to 88 in the cross-over group. SF-10 Psychosocial Health changed little in either group at the two timepoints.Treatment with burosumab improved Pain Interference and Fatigue beyond the MID in children with XLH who switched from conventional therapy to receive 24 weeks of burosumab. Improvements were also maintained in children who received an additional 24 weeks’ burosumab treatment.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Pediatrik (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Pediatrics (hsv//eng)
Publikations- och innehållstyp
- vet (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Padidela, Raja
-
Whyte, Michael P ...
-
Glorieux, Franci ...
-
Munns, Craig F.
-
Ward, Leanne M.
-
Nilsson, Ola, 19 ...
-
visa fler...
-
Portale, Anthony ...
-
Simmons, Jill H.
-
Namba, Noriyuki
-
Cheong, Hae Il
-
Pitukcheewanont, ...
-
Sochett, Etienne
-
Högler, Wolfgang
-
Muroya, Koji
-
Gottesman, Gary ...
-
Biggin, Andrew
-
Perwad, Farzana
-
Williams, Angela
-
Nixon, Annabel
-
Sun, Wei
-
Chen, Angel
-
Skrinar, Alison
-
Imel, Erik A.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Endokrinologi oc ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Pediatrik
- Artiklar i publikationen
-
Hormone Research ...
- Av lärosätet
-
Örebro universitet